Leo Gu

633 total citations
17 papers, 488 citations indexed

About

Leo Gu is a scholar working on Molecular Biology, Pharmaceutical Science and Immunology. According to data from OpenAlex, Leo Gu has authored 17 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Pharmaceutical Science and 4 papers in Immunology. Recurrent topics in Leo Gu's work include Drug Solubulity and Delivery Systems (4 papers), Protein Hydrolysis and Bioactive Peptides (4 papers) and Chemical Synthesis and Analysis (3 papers). Leo Gu is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Protein Hydrolysis and Bioactive Peptides (4 papers) and Chemical Synthesis and Analysis (3 papers). Leo Gu collaborates with scholars based in Poland, United States and Switzerland. Leo Gu's co-authors include Robert G. Strickley, Nancy Chu, Kwan Leung, William A. Lee, Andrew R. Miksztal, Gary C. Visor, Z.T. Chowhan, Naoki Kobayashi, Hitomi Kobayashi and Teruna J. Siahaan and has published in prestigious journals such as Journal of Neurochemistry, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.

In The Last Decade

Leo Gu

16 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leo Gu Poland 11 186 138 105 59 59 17 488
Henri Humbert France 15 77 0.4× 21 0.2× 43 0.4× 23 0.4× 17 0.3× 33 590
Derrick G. Freitag Canada 13 102 0.5× 105 0.8× 14 0.1× 41 0.7× 6 0.1× 21 391
Danny R. Howard United States 9 120 0.6× 16 0.1× 43 0.4× 35 0.6× 39 0.7× 15 502
Ilse R. Dubbelboer Sweden 11 87 0.5× 31 0.2× 49 0.5× 14 0.2× 14 0.2× 20 329
John Whitlam Australia 8 110 0.6× 99 0.7× 13 0.1× 6 0.1× 9 0.2× 22 392
C Vidal Germany 11 97 0.5× 226 1.6× 7 0.1× 19 0.3× 5 0.1× 16 463
G Fredj France 11 84 0.5× 39 0.3× 8 0.1× 10 0.2× 8 0.1× 40 483
Dwaipayan Mukherjee United States 11 339 1.8× 8 0.1× 20 0.2× 23 0.4× 53 0.9× 30 708
Shinji Kobuchi Japan 13 122 0.7× 17 0.1× 104 1.0× 27 0.5× 2 0.0× 61 529
Zuojun Li China 11 64 0.3× 15 0.1× 6 0.1× 27 0.5× 17 0.3× 52 348

Countries citing papers authored by Leo Gu

Since Specialization
Citations

This map shows the geographic impact of Leo Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Gu more than expected).

Fields of papers citing papers by Leo Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Gu. The network helps show where Leo Gu may publish in the future.

Co-authorship network of co-authors of Leo Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Leo Gu. A scholar is included among the top collaborators of Leo Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo Gu. Leo Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Jiajian, et al.. (2016). Effects of Fly Ash Microsphere on Flowability and Cohesiveness of Cement Paste. The HKU Scholars Hub (University of Hong Kong).
2.
Kobayashi, Naoki, et al.. (2007). Antigen-Specific Suppression of Experimental Autoimmune Encephalomyelitis by a Novel Bifunctional Peptide Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 322(2). 879–886. 38 indexed citations
3.
Chen, Jie, Timothy J. Falla, Hongjian Liu, et al.. (2000). Development of protegrins for the treatment and prevention of oral mucositis: Structure–activity relationships of synthetic protegrin analogues. Biopolymers. 55(1). 88–98. 3 indexed citations
4.
Gu, Leo & Jodi Fausnaugh. (1993). Stability and Characterization of Human Interleukin-1β. Pharmaceutical biotechnology. 5. 221–248. 3 indexed citations
5.
Brandl, Michael & Leo Gu. (1992). Degradation of tobramycin in aqueous solution. Drug Development and Industrial Pharmacy. 18(13). 1423–1436. 12 indexed citations
6.
Barnett, Jim, Joan M. Chow, Binh Nguyen, et al.. (1991). Physicochemical Characterization of Recombinant Human Nerve Growth Factor Produced in Insect Cells with a Baculovirus Vector. Journal of Neurochemistry. 57(3). 1052–1061. 18 indexed citations
7.
8.
9.
Lee, William A., et al.. (1990). Bioavailability Improvement of Mycophenolic Acid Through Amino Ester Derivatization. Pharmaceutical Research. 7(2). 161–166. 202 indexed citations
10.
Gu, Leo & Robert G. Strickley. (1990). A profound solvent effect on the diketopiperazine formation of the new dipeptide angiotensin-converting enzyme inhibitor, Moexipril. International Journal of Pharmaceutics. 60(2). 99–107. 11 indexed citations
11.
Strickley, Robert G., et al.. (1989). An Unexpected pH Effect on the Stability of Moexipril Lyophilized Powder. Pharmaceutical Research. 6(11). 971–975. 27 indexed citations
12.
Gu, Leo, James Dunn, & Charles A. Dvorak. (1989). Preformulation Prodrug Research - Chemical and Enzymatic Hydrolysis Kinetics of the Glycerol, Glycolic Acid and Morpholino Ethyl Ester Derivatives of a Developmental Analgesic Agent (RS-82917). Drug Development and Industrial Pharmacy. 15(2). 209–221. 6 indexed citations
13.
Gu, Leo & Robert G. Strickley. (1988). Preformulation Stability Studies of the New Dipeptide Angiotensin-Converting Enzyme Inhibitor RS-10029. Pharmaceutical Research. 5(12). 765–771. 13 indexed citations
14.
15.
Gu, Leo & Robert G. Strickley. (1987). Diketopiperazine Formation, Hydrolysis, and Epimerization of the New Dipeptide Angiotensin-Converting Enzyme Inhibitor RS-10085. Pharmaceutical Research. 4(5). 392–397. 36 indexed citations
16.
Visor, Gary C., et al.. (1987). Parenteral formulation development for the positive inotropic agent RS-82856: solubility and stability enhancement through complexation and lyophilization.. PubMed. 41(4). 120–5. 2 indexed citations
17.
Gu, Leo, et al.. (1987). Preformulation Selection of a Proper Salt for a Weak Acid-Base (Rs-82856) - A New Positive Inotropic Agent. Drug Development and Industrial Pharmacy. 13(3). 437–448. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henri Humbert Breakdown of academic impact, for papers by Derrick G. Freitag Breakdown of academic impact, for papers by Danny R. Howard Breakdown of academic impact, for papers by Ilse R. Dubbelboer Breakdown of academic impact, for papers by John Whitlam Breakdown of academic impact, for papers by C Vidal Breakdown of academic impact, for papers by G Fredj Breakdown of academic impact, for papers by Dwaipayan Mukherjee Breakdown of academic impact, for papers by Shinji Kobuchi Breakdown of academic impact, for papers by Zuojun Li
Rankless by CCL
2026